MENU
+Compare
GOSS
Stock ticker: NASDAQ
AS OF
Apr 23 closing price
Price
$0.89
Change
+$0.06 (+7.23%)
Capitalization
188M

GOSS Gossamer Bio Forecast, Technical & Fundamental Analysis

Gossamer Bio Inc is a clinical-stage biopharmaceutical company... Show more

GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for GOSS with price predictions
Apr 23, 2025

GOSS's RSI Oscillator ascends from oversold territory

The RSI Oscillator for GOSS moved out of oversold territory on April 11, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 33 similar instances when the indicator left oversold territory. In of the 33 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 64 cases where GOSS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 21, 2025. You may want to consider a long position or call options on GOSS as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GOSS just turned positive on April 23, 2025. Looking at past instances where GOSS's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GOSS advanced for three days, in of 261 cases, the price rose further within the following month. The odds of a continued upward trend are .

GOSS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

GOSS moved below its 50-day moving average on March 27, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for GOSS crossed bearishly below the 50-day moving average on April 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GOSS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for GOSS entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.854) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (1.754) is also within normal values, averaging (252.992).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GOSS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GOSS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

GOSS is expected to report earnings to rise 26.67% to -18 cents per share on May 13

Gossamer Bio GOSS Stock Earnings Reports
Q1'25
Est.
$-0.19
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.01
Q2'24
Missed
by $0.29
Q1'24
Est.
$-0.19
The last earnings report on March 13 showed earnings per share of -15 cents, beating the estimate of -17 cents. With 2.34M shares outstanding, the current market capitalization sits at 188.00M.
A.I. Advisor
published General Information

General Information

a company, which engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
3013 Science Park Road
Phone
+1 858 684-1300
Employees
135
Web
https://www.gossamerbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYESX157.65N/A
N/A
Rydex Energy Services A
HQIAX19.60N/A
N/A
Hartford Equity Income A
LGCYX15.94N/A
N/A
Lord Abbett Global Equity I
SXPRX43.25N/A
N/A
DWS S&P 500 Index R6
FIJZX43.05N/A
N/A
Fidelity Advisor Consumer Discret Z

GOSS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GOSS has been loosely correlated with MEIP. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GOSS jumps, then MEIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOSS
1D Price
Change %
GOSS100%
+7.51%
MEIP - GOSS
46%
Loosely correlated
N/A
CGEM - GOSS
45%
Loosely correlated
+0.12%
APVO - GOSS
41%
Loosely correlated
+4.05%
VIR - GOSS
41%
Loosely correlated
+2.76%
WHWK - GOSS
41%
Loosely correlated
+0.65%
More